My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Androgens, estrogens, and bone in men.

    Swerdloff RS, Wang C.

    Ann Intern Med. 2000 Dec 19;133(12):1002-4. No abstract available. PMID: 11119403 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Estrogens and euosteogenesis in men.

    Maugeri D, Panebianco P, Barbagallo P, Malaguarnera M, Curasi MP, Russo MS, Santangelo A, Speciale S, Scarpinato RA.

    Eur Rev Med Pharmacol Sci. 1998 Sep-Dec;2(5-6):189-92.PMID: 10710818 [PubMed - indexed for MEDLINE]Related articles

    3.

    Androgen replacement in aging men.

    Francis RM.

    Calcif Tissue Int. 2001 Oct;69(4):235-8. Review.PMID: 11730258 [PubMed - indexed for MEDLINE]Related articles

    4.

    Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

    Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM.

    J Clin Endocrinol Metab. 2001 Aug;86(8):3555-61.PMID: 11502778 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology.

    Rochira V, Balestrieri A, Madeo B, Zirilli L, Granata AR, Carani C.

    Eur J Endocrinol. 2006 Feb;154(2):175-85. Review.PMID: 16452530 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.

    Schubert M, Bullmann C, Minnemann T, Reiners C, Krone W, Jockenhövel F.

    Horm Res. 2003;60(1):21-8.PMID: 12792150 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism.

    Medras M, Jankowska EA, Rogucka E.

    Andrologia. 2001 Jan;33(1):47-52.PMID: 11167519 [PubMed - indexed for MEDLINE]Related articles

    8.

    Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism.

    Shabsigh A, Kang Y, Shabsign R, Gonzalez M, Liberson G, Fisch H, Goluboff E.

    J Sex Med. 2005 Sep;2(5):716-21.PMID: 16422830 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.

    Leder BZ, Finkelstein JS.

    Osteoporos Int. 2005 Dec;16(12):1487-94. Epub 2005 Apr 23.PMID: 15856361 [PubMed - indexed for MEDLINE]Related articles

    10.

    Androgens and aging men.

    Baulieu EE.

    Mol Cell Endocrinol. 2002 Dec 30;198(1-2):41-9. Review.PMID: 12573813 [PubMed - indexed for MEDLINE]Related articles

    11.

    Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study.

    Lorentzon M, Swanson C, Andersson N, Mellström D, Ohlsson C.

    J Bone Miner Res. 2005 Aug;20(8):1334-41. Epub 2005 Apr 11.PMID: 16007330 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Assessment of androgenic decline in the elderly]

    Campusano M C, Brusco G F, Campino J C, Rodríguez P L, Arteaga U E.

    Rev Med Chil. 2006 Sep;134(9):1123-8. Epub 2006 Dec 12. Spanish. PMID: 17171213 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.

    Merza Z, Blumsohn A, Mah PM, Meads DM, McKenna SP, Wylie K, Eastell R, Wu F, Ross RJ.

    Int J Androl. 2006 Jun;29(3):381-91. Epub 2005 Dec 22.PMID: 16390499 [PubMed - indexed for MEDLINE]Related articles

    14.

    Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden.

    Mellström D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C.

    J Bone Miner Res. 2006 Apr;21(4):529-35. Epub 2006 Apr 5.PMID: 16598372 [PubMed - indexed for MEDLINE]Related articles

    15.

    Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status.

    Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD.

    J Clin Endocrinol Metab. 2001 Jul;86(7):3162-5.PMID: 11443182 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Role of sex steroids in the regulation of bone morphology in men. The MINOS study.

    Szulc P, Uusi-Rasi K, Claustrat B, Marchand F, Beck TJ, Delmas PD.

    Osteoporos Int. 2004 Nov;15(11):909-17. Epub 2004 Jul 3.PMID: 15235765 [PubMed - indexed for MEDLINE]Related articles

    17.

    Impact of obesity on hypogonadism in the andropause.

    Tan RS, Pu SJ.

    Int J Androl. 2002 Aug;25(4):195-201. Review.PMID: 12121568 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients.

    Fassbender WJ, Balli M, Görtz B, Hinrichs B, Kaiser HE, Tracke HS.

    In Vivo. 2000 Sep-Oct;14(5):611-8.PMID: 11125545 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Symptomatic evaluation of late onset hypogonadism in healthy Chinese men]

    Li JY, Li XY, Li M, Zhang GK, Ma FL, Liu ZM, Zhang NY, Meng P.

    Zhonghua Nan Ke Xue. 2007 Apr;13(4):320-3. Chinese. PMID: 17491264 [PubMed - indexed for MEDLINE]Related articles

    20.

    Serum testosterone levels in South African men and the onset of androgen decline in ageing males.

    Bornman MS, Reif S.

    S Afr J Surg. 2007 May;45(2):62, 64. Review. No abstract available. PMID: 17674565 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity